GeoVax Labs Book Value Per Share Growth & History (GOVX)
GeoVax Labs's book value per share was $2.21 for fiscal 2025.
View full GeoVax Labs company overviewGeoVax Labs annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.21 | -$9.77 | −81.56% |
| 2024 | 2024-12-31 | $11.98 | -$60.90 | −83.56% |
| 2023 | 2023-12-31 | $72.87 | -$305.90 | −80.76% |
| 2022 | 2022-12-31 | $378.77 | $122.47 | +47.78% |
| 2021 | 2021-12-31 | $256.31 | -$672.15 | −72.39% |
| 2020 | 2020-12-31 | $928.45 | $88,649.96 | — |
| 2019 | 2019-12-31 | -$87,721.51 | -$36,437.27 | — |
| 2018 | 2018-12-31 | -$51,284.24 | -$51,261.68 | — |
| 2017 | 2017-12-31 | -$22.56 | -$55.20 | — |
| 2016 | 2016-12-31 | $32.64 | -$250.13 | −88.46% |
| 2015 | 2015-12-31 | $282.76 | $31.58 | +12.57% |
| 2014 | 2014-12-31 | $251.19 | -$150.13 | −37.41% |
| 2013 | 2013-12-31 | $401.32 | $65.52 | +19.51% |
| 2012 | 2012-12-31 | $335.80 | $14.86 | +4.63% |
| 2011 | 2011-12-31 | $320.94 | -$560.02 | −63.57% |
| 2010 | 2010-12-31 | $880.96 | -$967.58 | −52.34% |
| 2009 | 2009-12-31 | $1,848.54 | — | — |
GeoVax Labs quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.24 | -$4.19 | −94.61% |
| Q1 2026 | 2026-03-31 | $0.18 | -$14.09 | −98.77% |
| Q4 2025 | 2025-12-31 | $2.21 | -$9.77 | −81.56% |
| Q3 2025 | 2025-09-30 | $4.13 | -$20.56 | −83.28% |
| Q2 2025 | 2025-06-30 | $4.43 | $18.24 | — |
| Q1 2025 | 2025-03-31 | $14.27 | $13.68 | +2327.13% |
| Q4 2024 | 2024-12-31 | $11.98 | -$60.90 | −83.56% |
| Q3 2024 | 2024-09-30 | $24.69 | -$103.41 | −80.72% |
| Q2 2024 | 2024-06-30 | -$13.82 | -$257.21 | — |
| Q1 2024 | 2024-03-31 | $0.59 | -$323.67 | −99.82% |
| Q4 2023 | 2023-12-31 | $72.87 | -$305.90 | −80.76% |
| Q3 2023 | 2023-09-30 | $128.10 | -$324.45 | −71.69% |
| Q2 2023 | 2023-06-30 | $243.40 | -$400.26 | −62.19% |
| Q1 2023 | 2023-03-31 | $324.25 | -$126.34 | −28.04% |
| Q4 2022 | 2022-12-31 | $378.77 | $122.47 | +47.78% |
| Q3 2022 | 2022-09-30 | $452.55 | -$605.41 | −57.22% |
| Q2 2022 | 2022-06-30 | $643.66 | -$509.50 | −44.18% |
| Q1 2022 | 2022-03-31 | $450.59 | -$775.65 | −63.25% |
| Q4 2021 | 2021-12-31 | $256.31 | -$672.15 | −72.39% |
| Q3 2021 | 2021-09-30 | $1,057.96 | -$73.28 | −6.48% |
| Q2 2021 | 2021-06-30 | $1,153.16 | $2,359.81 | — |
| Q1 2021 | 2021-03-31 | $1,226.24 | $2,444.56 | — |
| Q4 2020 | 2020-12-31 | $928.45 | $88,649.96 | — |
| Q3 2020 | 2020-09-30 | $1,131.24 | $1,393.39 | — |
| Q2 2020 | 2020-06-30 | -$1,206.65 | $32,579.09 | — |
| Q1 2020 | 2020-03-31 | -$1,218.32 | $15,050.86 | — |
| Q4 2019 | 2019-12-31 | -$87,721.51 | -$36,437.27 | — |
| Q3 2019 | 2019-09-30 | -$262.15 | -$231.71 | — |
| Q2 2019 | 2019-06-30 | -$33,785.73 | -$33,751.92 | — |
| Q1 2019 | 2019-03-31 | -$16,269.18 | -$16,262.36 | — |
| Q4 2018 | 2018-12-31 | -$51,284.24 | -$51,261.68 | — |
| Q3 2018 | 2018-09-30 | -$30.45 | -$5.50 | — |
| Q2 2018 | 2018-06-30 | -$33.81 | -$74.16 | — |
| Q1 2018 | 2018-03-31 | -$6.82 | $25.76 | — |
| Q4 2017 | 2017-12-31 | -$22.56 | -$55.20 | — |
| Q3 2017 | 2017-09-30 | -$24.95 | -$89.41 | — |
| Q2 2017 | 2017-06-30 | $40.34 | $9.33 | +30.08% |
| Q1 2017 | 2017-03-31 | -$32.58 | -$160.23 | — |
| Q4 2016 | 2016-12-31 | $32.64 | -$250.13 | −88.46% |
| Q3 2016 | 2016-09-30 | $64.46 | -$376.83 | −85.39% |
| Q2 2016 | 2016-06-30 | $31.01 | -$551.82 | −94.68% |
| Q1 2016 | 2016-03-31 | $127.65 | -$609.99 | −82.69% |
| Q4 2015 | 2015-12-31 | $282.76 | $31.58 | +12.57% |
| Q3 2015 | 2015-09-30 | $441.29 | $183.82 | +71.39% |
| Q2 2015 | 2015-06-30 | $582.83 | $200.46 | +52.43% |
| Q1 2015 | 2015-03-31 | $737.64 | $155.61 | +26.74% |
| Q4 2014 | 2014-12-31 | $251.19 | -$150.13 | −37.41% |
| Q3 2014 | 2014-09-30 | $257.47 | -$235.32 | −47.75% |
| Q2 2014 | 2014-06-30 | $382.37 | -$164.70 | −30.11% |
| Q1 2014 | 2014-03-31 | $582.03 | $45.04 | +8.39% |
| Q4 2013 | 2013-12-31 | $401.32 | $65.52 | +19.51% |
| Q3 2013 | 2013-09-30 | $492.79 | -$62.13 | −11.20% |
| Q2 2013 | 2013-06-30 | $547.07 | -$63.73 | −10.43% |
| Q1 2013 | 2013-03-31 | $536.99 | -$110.81 | −17.11% |
| Q4 2012 | 2012-12-31 | $335.80 | $14.86 | +4.63% |
| Q3 2012 | 2012-09-30 | $554.92 | $2.55 | +0.46% |
| Q2 2012 | 2012-06-30 | $610.80 | -$57.59 | −8.62% |
| Q1 2012 | 2012-03-31 | $647.80 | — | — |
| Q4 2011 | 2011-12-31 | $320.94 | -$560.02 | −63.57% |
| Q3 2011 | 2011-09-30 | $552.37 | — | — |
| Q2 2011 | 2011-06-30 | $668.38 | — | — |
| Q4 2010 | 2010-12-31 | $880.96 | — | — |
GeoVax Labs book value per share trends
Over the last five fiscal years, GeoVax Labs's book value per share decreased from $928.45 to $2.21, a change of -$926.25. The latest reported quarter, Q2 2026, shows $0.24.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeoVax Labs source filings ↗